127 related articles for article (PubMed ID: 37935496)
1. [Follow-up analysis of sex hormone levels and prognosis in women after hematopoietic stem cell transplantation].
Xu QW; Du YY; Lyu KK; Xu MM; Gu CY; Kang HZ; Feng SL; Liu YJ; Wu DP; Han Y
Zhonghua Nei Ke Za Zhi; 2023 Nov; 62(11):1303-1310. PubMed ID: 37935496
[No Abstract] [Full Text] [Related]
2. Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.
Nakano H; Ashizawa M; Akahoshi Y; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
Int J Hematol; 2016 Jul; 104(1):110-6. PubMed ID: 27084256
[TBL] [Abstract][Full Text] [Related]
3. The uterine volume is dramatically decreased after hematopoietic stem cell transplantation during childhood regardless of the conditioning regimen.
Courbiere B; Drikes B; Grob A; Hamidou Z; Saultier P; Bertrand Y; Gandemer V; Plantaz D; Plat G; Poirée M; Ducassou S; Pochon C; Dalle JH; Thouvenin S; Paillard C; Kanold J; Sirvent A; Rousset-Jablonski C; Duros S; Gueniffey A; Cohade C; Boukaidi S; Frantz S; Agopiantz M; Poirot C; Genod A; Pirrello O; Gremeau AS; Bringer-Deutsch S; Auquier P; Michel G
Fertil Steril; 2023 Apr; 119(4):663-672. PubMed ID: 36627013
[TBL] [Abstract][Full Text] [Related]
4. Ovarian insufficiency following allogeneic hematopoietic stem cell transplantation.
Kawano M; Komura H; Kawaguchi H; Shimizu S; Yada-Hashimoto N; Shimizu M; Sato M; Inoue M; Ida S; Etani Y; Shoji Y; Nakacho M; Sawada K; Kimura T; Mitsuda N; Kurachi H
Gynecol Endocrinol; 2017 Feb; 33(2):156-159. PubMed ID: 27808585
[TBL] [Abstract][Full Text] [Related]
5. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation.
Bender JD; Oquendo-Del Toro H; Benoit J; Howell JC; Badia P; Davies SM; Grimley MS; Jodele S; Phillips C; Burns K; Marsh R; Nelson A; Wallace G; Dandoy CE; Pate A; Strine AC; Frias O; Breech L; Rose SR; Hoefgen H; Khandelwal P; Myers KC
Transplant Cell Ther; 2023 Feb; 29(2):130.e1-130.e8. PubMed ID: 36323400
[TBL] [Abstract][Full Text] [Related]
6. Ovarian tissue cryopreservation for fertility preservation before hematopoietic stem cell transplantation in patients with sickle cell disease: safety, ovarian function follow-up, and results of ovarian tissue transplantation.
Missontsa MM; Bernaudin F; Fortin A; Dhédin N; Pondarré C; Yakouben K; Neven B; Castelle M; Cavazzana M; Lezeau H; Peycelon M; Paye-Jaouen A; Sroussi J; Diesch-Furlanetto T; Barraud-Lange V; Sarnacki S; Fahd M; Marchand I; Delcour C; Vexiau D; Arlet JB; Kamdem A; Arnaud C; Dalle JH; Poirot C
J Assist Reprod Genet; 2024 Apr; 41(4):1027-1034. PubMed ID: 38358434
[TBL] [Abstract][Full Text] [Related]
7. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
[TBL] [Abstract][Full Text] [Related]
8. Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8-Gy total body irradiation-based reduced-toxicity myeloablative conditioning.
Komori K; Hirabayashi K; Morita D; Hara Y; Kurata T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Koike K; Nakazawa Y
Pediatr Transplant; 2019 May; 23(3):e13372. PubMed ID: 30714283
[TBL] [Abstract][Full Text] [Related]
9. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
[TBL] [Abstract][Full Text] [Related]
10. Updated Clinical Outcomes of Hematopoietic Stem Cell Transplantation Using Myeloablative Total Body Irradiation with Ovarian Shielding to Preserve Fertility.
Ashizawa M; Akahoshi Y; Nakano H; Kawamura S; Takeshita J; Yoshino N; Misaki Y; Yoshimura K; Gomyo A; Tamaki M; Kusuda M; Kameda K; Wada H; Kawamura K; Sato M; Terasako-Saito K; Tanihara A; Kimura SI; Nakasone H; Kako S; Akahane K; Wakatsuki M; Shirai K; Kanda Y
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2461-2467. PubMed ID: 31394267
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of ovarian tissue cryopreservation in female patients with hematological diseases for fertility preservation.
Wang YL; Zhai QJ; Wang ZH; Yang X; Wang JL; Zhu HL
Arch Gynecol Obstet; 2024 Jun; 309(6):2863-2880. PubMed ID: 38575798
[TBL] [Abstract][Full Text] [Related]
12. Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation.
Rotz SJ; Hamilton BK; Wei W; Ahmed I; Winston SA; Ballard S; Bernard RJ; Carpenter P; Farhadfar N; Ferraro C; Friend BD; Gloude NJ; Hayashi RJ; Hoyle K; Jenssen K; Koo J; Lee CJ; Mariano L; Nawabit R; Ngwube A; Lalefar N; Phelan R; Perkins L; Rao A; Rayes A; Sandheinrich T; Stafford L; Tomlinson K; Whiteside S; Wiedl C; Myers K
Transplant Cell Ther; 2024 May; 30(5):534.e1-534.e13. PubMed ID: 38342136
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study.
Çiftçiler R; Göker H; Demiroğlu H; Aladağ E; Aksu S; Haznedaroğlu İC; Sayınalp N; Özcebe O; Tekin F; Büyükaşık Y
Turk J Haematol; 2019 May; 36(2):88-96. PubMed ID: 30717586
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.
Cheng YC; Takagi M; Milbourne A; Champlin RE; Ueno NT
Oncologist; 2012; 17(2):233-8. PubMed ID: 22282904
[TBL] [Abstract][Full Text] [Related]
15. Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
Meacham LR; George S; Veludhandi A; Pruett MC; Haight AE; Arnold SD; Elchuri S; Stenger E; Krishnamurti L
Transplant Cell Ther; 2023 Aug; 29(8):531.e1-531.e4. PubMed ID: 37169288
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
[No Abstract] [Full Text] [Related]
17. Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts.
Lu Y; Xiong M; Sun RJ; Zhao YL; Zhang JP; Cao XY; Liu DY; Wei ZJ; Zhou JR; Lu DP
Hematology; 2021 Dec; 26(1):134-143. PubMed ID: 33491597
[No Abstract] [Full Text] [Related]
18. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.
Konopacki J; Porcher R; Robin M; Bieri S; Cayuela JM; Larghero J; Xhaard A; Andreoli AL; Dhedin N; Petropoulou A; Rodriguez-Otero P; Ribaud P; Moins-Teisserenc H; Carmagnat M; Toubert A; Chalandon Y; Socie G; Peffault de Latour R
Haematologica; 2012 May; 97(5):710-6. PubMed ID: 22180425
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Description of Gonadal Function in Sickle-cell Patients Treated With Hematopoietic Stem Cell Transplant Using Alkylator-based Conditioning Regimens.
Elchuri SV; Williamson Lewis R; Quarmyne MO; Haight AE; Cottrell HN; Meacham LR
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e575-e582. PubMed ID: 32205784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
